Analysis
$25I analysis on 6ix - valuation, growth, dividend & more for Immupharma Plc
Track Immupharma Plc (25I) on 6ix - releases, events, and the audience already following the stock.
Immupharma Plc
Run a Simply Wall St-style analysis on $25I (Immupharma Plc) - valuation, growth, past performance, dividend, ownership, and community notes on 6ix.